Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis

Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis

Background: Unresectable pancreatic ductal adenocarcinoma (UR-PDAC) has a poor prognosis. Conversion surgery is considered a promising strategy for improving the prognosis of UR-PDAC. This study aimed to investigate the clinical benefits of conversion surgery in patients with UR-PDAC. Methods: We re...

Full description

Bibliographic Details
Main Authors:	Yuko Mataki, Hiroshi Kurahara, Tetsuya Idichi, Kiyonori Tanoue, Yuto Hozaka, Yota Kawasaki, Satoshi Iino, Kosei Maemura, Hiroyuki Shinchi, Takao Ohtsuka
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Cancers
Subjects:	unresectable pancreatic ductal adenocarcinoma conversion surgery chemoradiotherapy
Online Access:	https://www.mdpi.com/2072-6694/13/5/1057

Similar Items

Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma
by: Hiroaki Yanagimoto, et al.
Published: (2020-05-01)

Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma
by: Sohei Satoi, et al.
Published: (2020-01-01)

A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
by: Alessio Bruni, et al.
Published: (2021-09-01)

Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy
by: Magdalena Zaborowska-Szmit, et al.
Published: (2021-09-01)

Gene Regulation by Antitumor miR-204-5p in Pancreatic Ductal Adenocarcinoma: The Clinical Significance of Direct RACGAP1 Regulation
by: Muhammad Khalid, et al.
Published: (2019-03-01)

Locally advanced cholangiolocellular carcinoma successfully treated with curative resection after downsizing chemotherapy: a case report
by: Yuto Hozaka, et al.
Published: (2021-01-01)

Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China
by: Tian X, et al.
Published: (2020-05-01)

Usefulness of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in primary cystadenocarcinoma of the mesentery: a case report
by: Yuto Hozaka, et al.
Published: (2020-12-01)

TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
by: Hideaki Bando, et al.
Published: (2020-04-01)

Palliative intraarterial chemoradiotherapy as a method of choice in the treatment of unresectable oropharyngeal tumors: a clinical case
by: R. V. Lutovinin, et al.
Published: (2021-01-01)

Unresectable hepatoblastoma: current perspectives
by: Trobaugh-Lotrario AD, et al.
Published: (2017-02-01)

Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma
by: Zhu Ji, et al.
Published: (2013-01-01)

Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis
by: Hiroki Shimomura, et al.
Published: (2020-09-01)

A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
by: Tomohiro Enokida, et al.
Published: (2020-03-01)

Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer
by: Bo Qiu, et al.
Published: (2016-07-01)

Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience
by: Naveen Kalra, et al.
Published: (2013-04-01)

Molecular Pathogenesis and Regulation of the <i>miR-29-3p</i>-Family: Involvement of <i>ITGA6</i> and <i>ITGB1</i> in Intra-Hepatic Cholangiocarcinoma
by: Yuto Hozaka, et al.
Published: (2021-06-01)

Is there a place for liver transplantation in cases with unresectable central cholangiocarcinoma?
by: Nicolae Bacalbașa, et al.
Published: (2018-11-01)

Laparoscopic gastric partitioning gastrojejunostomy for an unresectable duodenal malignant tumor
by: Matsumoto Toshifumi, et al.
Published: (2005-01-01)

Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma
by: Teiichi Sugiura, et al.
Published: (2020-07-01)

Unresectable Advanced Gastric Cancer with Skin Invasion followed by Total Gastrectomy after Second-Line Chemotherapy
by: Hidenori Maki, et al.
Published: (2019-08-01)

Chemoradiation in Unresectable Oral Cavity Cancer: A Myth or Reality!
by: Vijay Maruti Patil, et al.
Published: (2020-10-01)

Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of <i>miR-30c-5p</i> and <i>miR-30c-2-3p</i> Regulation on Oncogenic Genes
by: Takako Tanaka, et al.
Published: (2020-09-01)

Esophageal stenting for unresectable cancer (review of literature)
by: N. S. Popova, et al.
Published: (2021-01-01)

The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series
by: Pichit Sittitrai, et al.
Published: (2018-10-01)

Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies
by: Shuiqing Wu, et al.
Published: (2018-04-01)

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
by: Personeni N, et al.
Published: (2019-01-01)

Hepatic Arterial Infusion Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma, a Comprehensive Review
by: Marco Massani, et al.
Published: (2021-06-01)

Current Surgical Aspects of Palliative Treatment for Unresectable Pancreatic Cancer
by: Konstantinos Karapanos, et al.
Published: (2011-02-01)

Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis
by: Rong-xin Zhang, et al.
Published: (2017-07-01)

Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
by: Pei-Chang Lee, et al.
Published: (2020-01-01)

Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer
by: Zaisheng Ye, et al.
Published: (2021-06-01)

A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy
by: Ranpu Wu, et al.
Published: (2021-07-01)

Efficacy of EUS-guided FNB using a Franseen needle for tissue acquisition and microsatellite instability evaluation in unresectable pancreatic lesions
by: Mitsuru Sugimoto, et al.
Published: (2020-11-01)

Role of palliative radiotherapy in unresectable intrahepatic cholangiocarcinoma: population-based analysis with propensity score matching
by: Shao F, et al.
Published: (2018-06-01)

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group
by: Jacob S. Parzen, et al.
Published: (2020-11-01)

NEW OPPORTUNITIES FOR SURGICAL TREATMENT OF PATIENTS WITH INITIALLY UNRESECTABLE UTERINE CERVIX CANCE
by: I. A. Kosenko, et al.
Published: (2016-04-01)

Separation Surgery for Unresectable Right-sided Colon Cancer as Palliation
by: Ryosuke Maki, et al.
Published: (2021-04-01)

Successful radical surgical resection of initially unresectable intrahepatic cholangiocarcinoma by downsizing chemotherapy with gemcitabine plus cisplatin: a case report
by: Ryosuke Takayanagi, et al.
Published: (2017-11-01)

Unresectable bulky chest wall recurrent breast cancer controlled with CT-guided interstitial high-dose-rate brachytherapy and external beam radiotherapy with adjuvant hormonal therapy – case report
by: Hiroaki Kunogi, et al.
Published: (2021-08-01)